Data News > Lawsuits Filed Against TransMedics and Treace Medical Concepts for Securities Law Violations
- Multiple law firms have filed class action lawsuits against TransMedics Group, Inc. for alleged violations of federal securities laws.
- Shareholders who suffered losses on their investments in TransMedics are encouraged to seek potential recovery under the securities laws.
- A lead plaintiff deadline of April 15, 2025, has been set for investors in TransMedics Group, Inc.
- Treace Medical Concepts, Inc. is also facing a securities class action lawsuit filed by Scott+Scott Attorneys at Law LLP.
- Investors who purchased or acquired securities from Treace Medical Concepts between May 8, 2023, and May 7, 2024, are included in the class action lawsuit.
Levi & Korsinsky, a prominent law firm, has issued a reminder to shareholders of TransMedics Group, Inc. about the upcoming lead plaintiff deadline of April 15, 2025, in relation to a lawsuit filed against the company. Investors who have experienced losses on their investment in TransMedics Group, Inc. (NASDAQ: TMDX) are urged to explore the possibility of recovering their losses under the federal securities laws. This invitation to seek further information is extended by Levi & Korsinsky through a provided link or by contacting Joseph E. Levi, Esq.
Another leading law firm, Rosen, is advising investors of TransMedics Group, Inc. with losses exceeding $50,000 to seek legal counsel before the crucial deadline of April 15, 2025, in a securities class action lawsuit initially filed by the firm. The city of New York saw this development on April 11, 2025, marking a significant moment in the legal proceedings concerning TransMedics Group, Inc. and its alleged securities law violations.
Scott+Scott Attorneys at Law LLP, a respected international litigation firm, has initiated a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (NASDAQ: TMCI). The lawsuit includes claims under various sections of the Securities Exchange Act of 1934 on behalf of individuals who acquired Treace Medical securities during the defined Class Period, between May 8, 2023, and May 7, 2024, and suffered damages as a result. This legal action is officially known as McCluney v. Treace Medical Concepts, Inc., et al., Case No. 3:25-cv-00390.
In light of the legal proceedings surrounding TransMedics Group, Inc., investors are reminded to be proactive in securing their rights. Multiple law firms have filed class action lawsuits against the company for alleged violations of federal securities laws. The legal actions involve potential recovery options for investors who may have suffered losses on their investments in TransMedics Group, Inc., highlighting the importance of understanding and utilizing the provisions under the securities laws. Investors are urged to take action and explore their options before the looming deadline.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
For more information:
Earning Price Impact Earning Estimates Earning Call Transcript
Lawsuits Filed Against TransMedics and Treace Medical Concepts for Securities Law Violations
By KlickAnalytics Data Insights | April 11, 2025 08:01PM ET
Key Points
- Multiple law firms have filed class action lawsuits against TransMedics Group, Inc. for alleged violations of federal securities laws.
- Shareholders who suffered losses on their investments in TransMedics are encouraged to seek potential recovery under the securities laws.
- A lead plaintiff deadline of April 15, 2025, has been set for investors in TransMedics Group, Inc.
- Treace Medical Concepts, Inc. is also facing a securities class action lawsuit filed by Scott+Scott Attorneys at Law LLP.
- Investors who purchased or acquired securities from Treace Medical Concepts between May 8, 2023, and May 7, 2024, are included in the class action lawsuit.
Levi & Korsinsky, a prominent law firm, has issued a reminder to shareholders of TransMedics Group, Inc. about the upcoming lead plaintiff deadline of April 15, 2025, in relation to a lawsuit filed against the company. Investors who have experienced losses on their investment in TransMedics Group, Inc. (NASDAQ: TMDX) are urged to explore the possibility of recovering their losses under the federal securities laws. This invitation to seek further information is extended by Levi & Korsinsky through a provided link or by contacting Joseph E. Levi, Esq.
Another leading law firm, Rosen, is advising investors of TransMedics Group, Inc. with losses exceeding $50,000 to seek legal counsel before the crucial deadline of April 15, 2025, in a securities class action lawsuit initially filed by the firm. The city of New York saw this development on April 11, 2025, marking a significant moment in the legal proceedings concerning TransMedics Group, Inc. and its alleged securities law violations.
Scott+Scott Attorneys at Law LLP, a respected international litigation firm, has initiated a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (NASDAQ: TMCI). The lawsuit includes claims under various sections of the Securities Exchange Act of 1934 on behalf of individuals who acquired Treace Medical securities during the defined Class Period, between May 8, 2023, and May 7, 2024, and suffered damages as a result. This legal action is officially known as McCluney v. Treace Medical Concepts, Inc., et al., Case No. 3:25-cv-00390.
In light of the legal proceedings surrounding TransMedics Group, Inc., investors are reminded to be proactive in securing their rights. Multiple law firms have filed class action lawsuits against the company for alleged violations of federal securities laws. The legal actions involve potential recovery options for investors who may have suffered losses on their investments in TransMedics Group, Inc., highlighting the importance of understanding and utilizing the provisions under the securities laws. Investors are urged to take action and explore their options before the looming deadline.
For more information:
For more information:
To view full story, Upgrade to PRO plan!
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.